Global Nuclear Medicine Outlook 2020
Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population.
According to our research report, Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.
Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.
Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.
The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.
According to our research report, Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.
Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.
Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.
The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. DRIVERS AND CHALLENGES
3.1 Drivers
3.1.1 Rising Incidences of Cancer and Cardiovascular Diseases
3.1.2 Increasing Use of SPECT and PET Scans
3.1.3 Rising Ageing Population
3.1.4 Advances in Radiotracers
3.2 Challenges
3.2.1 Shut Down of Nuclear Reactors
3.2.2 Short Half-life of Radiopharmaceuticals
3.2.3 Production and Quality Control Challenges
3.2.4 Reimbursement Issues
4. INDUSTRY OVERVIEW
4.1 Nuclear Medicine Diagnostics Market
4.1.1 Diagnostic Radiopharmaceuticals Market
4.1.2 Nuclear Medicine Equipments Market
4.2 Nuclear Medicine Therapeutics Market
4.3 Nuclear Medicine Market by Geography
5. RECENT TRENDS AND DEVELOPMENTS
5.1 Nuclear Medicine: Aiding the Growth of Personalized Medicine
5.2 Shift from SPECT to PET Systems
5.3 Hybrid Imaging Propelling Market Growth
5.4 Efforts Underway to Overcome Molybdenum-99 Shortage
5.5 Consolidation in the Market
5.6 Increasing Number of Clinical Trials
6. COMPETITIVE LANDSCAPE
6.1 Advanced Accelerator Applications
6.2 Mallinckrodt
6.3 Lantheus Medical Imaging
6.4 IBA
6.5 Cardinal Health Inc.
6.6 Nordion Inc.
6.7 Siemens Healthcare
6.8 GE Healthcare
2. RESEARCH METHODOLOGY
3. DRIVERS AND CHALLENGES
3.1 Drivers
3.1.1 Rising Incidences of Cancer and Cardiovascular Diseases
3.1.2 Increasing Use of SPECT and PET Scans
3.1.3 Rising Ageing Population
3.1.4 Advances in Radiotracers
3.2 Challenges
3.2.1 Shut Down of Nuclear Reactors
3.2.2 Short Half-life of Radiopharmaceuticals
3.2.3 Production and Quality Control Challenges
3.2.4 Reimbursement Issues
4. INDUSTRY OVERVIEW
4.1 Nuclear Medicine Diagnostics Market
4.1.1 Diagnostic Radiopharmaceuticals Market
4.1.2 Nuclear Medicine Equipments Market
4.2 Nuclear Medicine Therapeutics Market
4.3 Nuclear Medicine Market by Geography
5. RECENT TRENDS AND DEVELOPMENTS
5.1 Nuclear Medicine: Aiding the Growth of Personalized Medicine
5.2 Shift from SPECT to PET Systems
5.3 Hybrid Imaging Propelling Market Growth
5.4 Efforts Underway to Overcome Molybdenum-99 Shortage
5.5 Consolidation in the Market
5.6 Increasing Number of Clinical Trials
6. COMPETITIVE LANDSCAPE
6.1 Advanced Accelerator Applications
6.2 Mallinckrodt
6.3 Lantheus Medical Imaging
6.4 IBA
6.5 Cardinal Health Inc.
6.6 Nordion Inc.
6.7 Siemens Healthcare
6.8 GE Healthcare
LIST OF FIGURES:
Figure 3-1: World - Number of Cancer Cases (Million), 2015 & 2035
Figure 3-2: World - Population Aged 60 and Above (Billion), 2014 & 2050
Figure 4-1: Global - Nuclear Medicine Market (Billion US$), 2014-2020
Figure 4-2: Nuclear Medicine Market Segmentation by Application (%), 2014
Figure 4-3: Nuclear Medicine Market Segmentation by Application (%), 2020
Figure 4-4: Nuclear Medicine Diagnostics Market Segmentation (%), 2014
Figure 4-5: Nuclear Medicine Diagnostics Market Segmentation (%), 2020
Figure 4-6: Global - Nuclear Medicine Diagnostics Market (Billion US$), 2014-2020
Figure 4-7: Medical Procedures Using Technetium - 99m (%), 2014
Figure 4-8: Global - Diagnostic Radiopharmaceuticals Market (Billion US$), 2014-2020
Figure 4-9: Global - Nuclear Medicine Equipments Market (Billion US$), 2014-2020
Figure 4-10: Global - Nuclear Medicine Therapeutics Market (Billion US$), 2014-2020
Figure 4-11: Global - Nuclear Medicine Market by Geographies (%), 2014
Figure 3-1: World - Number of Cancer Cases (Million), 2015 & 2035
Figure 3-2: World - Population Aged 60 and Above (Billion), 2014 & 2050
Figure 4-1: Global - Nuclear Medicine Market (Billion US$), 2014-2020
Figure 4-2: Nuclear Medicine Market Segmentation by Application (%), 2014
Figure 4-3: Nuclear Medicine Market Segmentation by Application (%), 2020
Figure 4-4: Nuclear Medicine Diagnostics Market Segmentation (%), 2014
Figure 4-5: Nuclear Medicine Diagnostics Market Segmentation (%), 2020
Figure 4-6: Global - Nuclear Medicine Diagnostics Market (Billion US$), 2014-2020
Figure 4-7: Medical Procedures Using Technetium - 99m (%), 2014
Figure 4-8: Global - Diagnostic Radiopharmaceuticals Market (Billion US$), 2014-2020
Figure 4-9: Global - Nuclear Medicine Equipments Market (Billion US$), 2014-2020
Figure 4-10: Global - Nuclear Medicine Therapeutics Market (Billion US$), 2014-2020
Figure 4-11: Global - Nuclear Medicine Market by Geographies (%), 2014
LIST OF TABLES:
Table 5-1: Recent M&A in the Global Nuclear Medicine Market (2014 - 2015)
Table 5-2: Major Products in the Pipeline
Table 6-1: Advanced Accelerator Applications - Revenue by Product Category (Million Euro), 2013 & 2014
Table 6-2: Advanced Accelerator Applications - Revenue by Countries (Million Euro), 2013 & 2014
Table 6-3: Advanced Accelerator Applications - Strengths & Weaknesses
Table 6-4: Mallinckrodt - Revenue by Business Segments (Million US$), 2013 & 2014
Table 6-5: Mallinckrodt - Revenue Breakup for Global Medical Imaging Segment (Million US$), 2013 & 2014
Table 6-6: Mallinckrodt - Strengths & Weaknesses
Table 6-7: Lantheus Medical Imaging - Revenue by Products (Million US$), 2013 & 2014
Table 6-8: Lantheus Medical Imaging - Strengths & Weaknesses
Table 6-9: IBA - Revenue by Business Segments (Million Euro), 2013 & 2014
Table 6-10: IBA - Strengths & Weaknesses
Table 6-11: Cardinal Health Inc. - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 6-12: Cardinal Health Inc. - Strengths & Weaknesses
Table 6-13: Nordion Inc. - Strengths & Weaknesses
Table 6-14: Siemens Healthcare - Strengths and Weaknesses
Table 6-15: GE Healthcare - Strengths and Weaknesses
Table 5-1: Recent M&A in the Global Nuclear Medicine Market (2014 - 2015)
Table 5-2: Major Products in the Pipeline
Table 6-1: Advanced Accelerator Applications - Revenue by Product Category (Million Euro), 2013 & 2014
Table 6-2: Advanced Accelerator Applications - Revenue by Countries (Million Euro), 2013 & 2014
Table 6-3: Advanced Accelerator Applications - Strengths & Weaknesses
Table 6-4: Mallinckrodt - Revenue by Business Segments (Million US$), 2013 & 2014
Table 6-5: Mallinckrodt - Revenue Breakup for Global Medical Imaging Segment (Million US$), 2013 & 2014
Table 6-6: Mallinckrodt - Strengths & Weaknesses
Table 6-7: Lantheus Medical Imaging - Revenue by Products (Million US$), 2013 & 2014
Table 6-8: Lantheus Medical Imaging - Strengths & Weaknesses
Table 6-9: IBA - Revenue by Business Segments (Million Euro), 2013 & 2014
Table 6-10: IBA - Strengths & Weaknesses
Table 6-11: Cardinal Health Inc. - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 6-12: Cardinal Health Inc. - Strengths & Weaknesses
Table 6-13: Nordion Inc. - Strengths & Weaknesses
Table 6-14: Siemens Healthcare - Strengths and Weaknesses
Table 6-15: GE Healthcare - Strengths and Weaknesses
